WCN26-6423 Pemigatinib-Associated Calciphylaxis versus Calcinosis Cutis in Metastatic Cholangiocarcinoma

Read full text Summarise with VIRAT
Authors: Archee Singh, Kirsten S. Hepburn, Ken W. T. Chau
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Calciphylaxis is a severe complication of mineral bone disorder in patients with kidney failure, especially those on dialysis. When it occurs in individuals without Kidney Failure, it is termed non-uraemic calciphylaxis, a rarer entity with unclear pathophysiology and a high mortality rate, often due to sepsis. Increasingly, non-uraemic calciphylaxis is recognized in patients receiving targeted therapies such as fibroblast growth factor receptor inhibitors. Distinguishing calciphylaxis from calcinosis cutis is critical for prognosis and management.

Fields of Study & Subjects

Parathyroid Disorders and Treatments Dermatological and Skeletal Disorders Bone health and treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104166–104166
Publication date
25 March 2026
Language
EN